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Operative Blood Loss and Survival
in Pancreatic Cancer
K azanjian et al
1 recently reported determinants of
survival in 182 patients who underwent pan-
creaticoduodenectomy for adenocarcinoma of
the pancreatic head. Through multivariate analysis, the
authors found that operative estimated blood loss (EBL)
and time of surgery (1987-1995 or 1996-2005) were sig-
nificantly related to survival, whereas perioperative blood
transfusion was not. We have 3 comments on this im-
portant study. First, the significance of EBL should be
interpreted with caution, because this variable is highly
subjective and notoriously inaccurate.2-4 Simulations have
found that operative personnel (including surgeons) vi-
sually underestimate EBL. Because surgeons have an ob-
vious bias, which is amplified when EBL becomes a per-
formance indicator or the end point of a study, it is not
surprising that the most accurate estimations of EBL are
from anesthesiologists.2
Second, the lack of significance for perioperative trans-
fusion should be interpreted with caution because pa-
tients who undergo pancreaticoduodenectomy may re-
ceive blood preoperatively for anemia, postoperatively
during adjuvant therapy, or at other points during their
overall care. Consideration of nonperioperative transfu-
sions is essential.
Third, while we fully agree that minimization of EBL
and blood transfusion is important and more than 90%
of our patients do not receive transfusions, the effect of
patient selection must be acknowledged. For example,
modern imaging has allowed early recognition of meta-
static disease and precise assessment of perivascular
planes. Furthermore, increaseduse of neoadjuvant therapy
removes patients who develop early metastatic disease
from the operative pool, and performance status has been
recognized as being important. Attention to these and
other patient selection factors canminimize EBL and im-
prove postoperative survival.
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In reply
We thank Drs Conway and Gagandeep for their comments.
We agree that the EBL is less accurate than one might wish,
and in our review of the University of California–Los Ange-
les experience with resection for pancreatic cancer, the re-
cordedEBLvaluewas that of the anesthesiologist’s, taken from
the operative record. Because our report is a retrospective case
series, the suggestion thatEBLvalueswere biased because they
were being used as a performance indicator or end point is in-
correct. The anesthesiologists (none of whomwere coauthors
of the article) “called it as they saw it” during the entire study
period, and the data speak for themselves.
Drs Conway and Gagandeep also suggest that the selec-
tion of patientswith less aggressive or advanced diseasemight
allow for resections with less blood loss and that such pa-
tients might inherently have better prognoses. On the con-
trary, we found no evidence to support that contention and
discussed this in the article. In support of this, there were
no differences in the degree of tumor differentiation, the in-
cidence of R1 resections (positive resection margins), or the
frequency of lymph node metastases or perineural invasion
in the 2 groups.
The lack of a relationship between prognosis and blood
transfusion is curious. However, the 5-year survival for pa-
tients who received a blood transfusion was less than half
than that of those who did not (14.3 vs 34.2 months), and
this was significant on univariate analysis (P=.008). Pa-
tients most certainly do receive blood at times other than
the perioperative period, but it is unclear how this would
affect the significance of our observations or recommenda-
tions that surgeons should strive for a technically precise
operation with minimal blood loss.
Most statistics about pancreatic adenocarcinoma con-
tinue to be depressing, andmany in the generalmedical com-
munity may even be reluctant to refer patients with resect-
able disease for surgical resection. This is suggested by the
recent finding that almost 40% of patients with early stage
disease in the United States do not undergo pancreatico-
duodenectomy.1 It may reflect pessimism that is still preva-
lent in the community based on a presumed high operative
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mortality rate for resection and the low likelihood of long-
term survival even after successful resection. Thus, pa-
tients are not even referred for surgical evaluation. We, as
well as other high-volume centers, have had no operative
deaths in our entire series. The finding that patients can look
forward to a 5-year survival rate of 35.5% is good news in-
deed. These observations need to be disseminatedmorewidely.
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Correction
Middle Initial Missing From Author Name. In the ar-
ticle titled “Laryngeal Complications After Thyroidec-
tomy: Is It Always the Surgeon?” by Echternach et al,
published in the February issue of the Archives (2009;
144[2]:149-153), the second author’s middle initial was
omitted from the byline on page 149. It should have read
as follows: Christoph A. Maurer, MD.
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